Video

Dr. Roboz on Recent Therapeutic Developments in AML

Author(s):

Gail J. Roboz, MD, discusses recent therapeutics developments in the treatment of patients with acute myeloid leukemia.

Gail J. Roboz, MD, professor of medicine, and director of the Clinical and Translational Leukemia Program, Weill Medical College of Cornell University, discusses recent therapeutics developments in the treatment of patients with acute myeloid leukemia (AML).

For decades, very few advances were made in the treatment of this patient population, despite multiple clinical trials, according to Roboz. However, this has changed, with 9 new approved approaches in just the past few years, Roboz says. The approvals span a variety of different types of therapy, including cytotoxic chemotherapy, as well as several targeted therapies; these options have collectively changed the treatment landscape of AML, Roboz notes. 

Many treatments, both as single agents and in combination, have been adopted as new standards of care. However, there is still work to be done to find curative treatments for this patient population, Roboz concludes.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity
Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing
Video

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Jun 5th 2025 - Jul 12th 2025

online-activity